Vascular endothelial growth factor-A level in human breast milk after intravitreal injection of ranibizumab: a case report

BACKGROUND: Ranibizumab is one of intravitreal anti-vascular endothelial growth factor agents. It is applied in the treatments of choroidal neovascularization, age-related macular degeneration, diabetic macular edema, and macular edema secondary to retinal vein occlusion. Preliminary evidence sugges...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ying, Zhou, Rong, Sun, Zuhua, Zheng, Yihan, Lin, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969248/
https://www.ncbi.nlm.nih.gov/pubmed/35361227
http://dx.doi.org/10.1186/s13006-022-00463-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969248/
https://www.ncbi.nlm.nih.gov/pubmed/35361227
http://dx.doi.org/10.1186/s13006-022-00463-y

Ejemplares similares